Issue 4, 2021

A multi-effective and long-acting immunotherapy through one single hydrogel based injection

Abstract

A dual-effective (photothermal and immune) therapy employing gold nanorods (AuNRs) with a drug (two macrophage migration inhibitory factor (MIF) inhibitors) sustained release hydrogel was designed in this paper. The subsequent cellular and animal studies demonstrated that the proposed therapy can not only inhibit the proliferation, migration, and recurrence of cancer cells, but also improve the immune function (increase the infiltration of CD8+ killer T cells in tumors) without the traditional multiple injections of expensive immune drugs.

Graphical abstract: A multi-effective and long-acting immunotherapy through one single hydrogel based injection

Supplementary files

Article information

Article type
Paper
Submitted
19 Nov 2020
Accepted
28 Nov 2020
First published
10 Dec 2020

Biomater. Sci., 2021,9, 1374-1380

A multi-effective and long-acting immunotherapy through one single hydrogel based injection

M. Wang, X. Cheng, L. Luo, Y. Liu, F. Cao, S. Zhao, H. Peng, C. Hong, L. Jin, L. Deng, H. Xin and X. Wang, Biomater. Sci., 2021, 9, 1374 DOI: 10.1039/D0BM01974G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements